Skip to main content
. 2021 Nov;50(11):2161–2171. doi: 10.18502/ijph.v50i11.7570

Table 3:

Subgroup meta-analysis of the administration route with respect to the total efficacy rate of mecobalamin in DGP

Subgroup Model for meta-analysis No. of trials Effect size (95%CI) P-value I2 (%) Q-statistics (P)
mecobalamin im FE 10 3.54 (2.29–5.46) <0.001 0 0.95
mecobalamin po 14 5.24 (3.62–7.59) <0.001 0 0.94

po, oral; im, intramuscular injection; FE, fixed -effects model.